PDS Biotechnology Corporation EU6.F Stock
PDS Biotechnology Corporation Price Chart
PDS Biotechnology Corporation EU6.F Financial and Trading Overview
PDS Biotechnology Corporation stock price | 3.17 EUR |
Previous Close | 5.49 EUR |
Open | 5.6 EUR |
Bid | 5.58 EUR x 0 |
Ask | 5.78 EUR x 0 |
Day's Range | 5.6 - 5.6 EUR |
52 Week Range | 2.94 - 12.58 EUR |
Volume | 1.5K EUR |
Avg. Volume | 32 EUR |
Market Cap | 172.61M EUR |
Beta (5Y Monthly) | 1.847405 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.29 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 19.71 EUR |
EU6.F Valuation Measures
Enterprise Value | 145.1M EUR |
Trailing P/E | N/A |
Forward P/E | -6.8292685 |
PEG Ratio (5 yr expected) | -0.29 |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 4.1947565 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -3.41 |
Trading Information
PDS Biotechnology Corporation Stock Price History
Beta (5Y Monthly) | 1.847405 |
52-Week Change | 106.26% |
S&P500 52-Week Change | 20.43% |
52 Week High | 12.58 EUR |
52 Week Low | 2.94 EUR |
50-Day Moving Average | 6.14 EUR |
200-Day Moving Average | 6.56 EUR |
EU6.F Share Statistics
Avg. Volume (3 month) | 32 EUR |
Avg. Daily Volume (10-Days) | 160 EUR |
Shares Outstanding | 30.82M |
Float | 29.44M |
Short Ratio | N/A |
% Held by Insiders | 4.48% |
% Held by Institutions | 22.40% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -41.13% |
Return on Equity (ttm) | -86.78% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -42552508 EUR |
Net Income Avi to Common (ttm) | -42041252 EUR |
Diluted EPS (ttm) | -1.5 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 65.2M EUR |
Total Cash Per Share (mrq) | 2.12 EUR |
Total Debt (mrq) | 23.51M EUR |
Total Debt/Equity (mrq) | 57.32 EUR |
Current Ratio (mrq) | 16.46 |
Book Value Per Share (mrq) | 1.335 |
Cash Flow Statement
Operating Cash Flow (ttm) | -32529332 EUR |
Levered Free Cash Flow (ttm) | -23246652 EUR |
Profile of PDS Biotechnology Corporation
Country | Germany |
State | NJ |
City | Florham Park |
Address | 25B Vreeland Road |
ZIP | 07932 |
Phone | 800 208 3343 |
Website | https://www.pdsbiotech.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 26 |
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, and human papillomavirus associated malignancies. The company is developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.
Q&A For PDS Biotechnology Corporation Stock
What is a current EU6.F stock price?
PDS Biotechnology Corporation EU6.F stock price today per share is 3.17 EUR.
How to purchase PDS Biotechnology Corporation stock?
You can buy EU6.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PDS Biotechnology Corporation?
The stock symbol or ticker of PDS Biotechnology Corporation is EU6.F.
Which industry does the PDS Biotechnology Corporation company belong to?
The PDS Biotechnology Corporation industry is Biotechnology.
How many shares does PDS Biotechnology Corporation have in circulation?
The max supply of PDS Biotechnology Corporation shares is 36.87M.
What is PDS Biotechnology Corporation Price to Earnings Ratio (PE Ratio)?
PDS Biotechnology Corporation PE Ratio is now.
What was PDS Biotechnology Corporation earnings per share over the trailing 12 months (TTM)?
PDS Biotechnology Corporation EPS is -1.29 EUR over the trailing 12 months.
Which sector does the PDS Biotechnology Corporation company belong to?
The PDS Biotechnology Corporation sector is Healthcare.